This podcast series was initiated and fully funded by Sanofi. The content has been reviewed and approved by the sponsoring company and speakers prior to broadcast. Editorial support for this podcast was provided by OmniaMed Communications. GPnotebook has had no input into the content of this podcast series. © 2022 Sanofi

Biosimilar insulin in practice (Promotional content from Sanofi)

Diabetes and endocrinology

7 November 2022

MAT-XU-2202805 (v1.0) I October 2022

In this episode, Dr Amar Puttana, Dr Patrick Holmes and Dr Shafie Kamaruddin will discuss the evolving role of biosimilar insulin in the management of diabetes, how to assess biosimilar treatment options and incorporate their use into practice.

For GB Healthcare Professionals only

GB Prescribing information for Admelog (Insulin lispro 100 units/ml) can be accessed by clicking here.

GB Prescribing Information for Trurapi▼ (Insulin aspart 100 units/ml) can be accessed by clicking here.

Adverse events should be reported.

Great Britain reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Sanofi Tel: 0800 090 2314. Alternatively, send via email to [email protected].

MAT-XU-2204698 (v1.0) I December 2022